Posters

Non-penetrating artificial cornea for primary treatment of non-inflammatory corneal blindness

Poster Details

First Author: Y.Shiuey USA

Co Author(s):                        

Abstract Details

Purpose:

We investigated the use of a Non-penetrating Artificial Cornea as a primary procedure in patients with non-inflammatory causes of corneal blindness

Setting:

A private cornea subspecialty clinic in Valencia Venezuela

Methods:

Twenty patients with non-inflammatory causes of corneal blindness (VA,20/200) were implanted with the KeraKlear non-penetrating artificial cornea using the Ziemer Z6 femtosecond laser. 11 patients had anterior corneal scars, 3 patients had Fuchs' endothelial dystrophy, 2 patients had keratoconus, 2 patients had stromal dystrophy, 1 patient had pseudophakic bullous keratopathy, 1 patient had a chemical burn. 1 patient with a corneal scar also had a central macular scar. IRB approval was obtained for the study and the study conformed to the guidelines established in the declaration of Helsinki.

Results:

The average follow-up period was 47 months. 85% of patients achieved better than 20/200 after the implantation of the non-penetrating artificial cornea. The non-penetrating artificial cornea was retained at the last follow up visit in 90% of patients.

Conclusions:

Non-penetrating artificial cornea is a viable option as a primary procedure in patients with non-inflammatory causes of corneal blindness. This method of treating corneal blindness can significantly decrease the burden of corneal blindness world-wide.

Financial Disclosure:

... gains financially from product or procedure presented